These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9203822)
1. A European perspective on regulation and technology. Sharp J PDA J Pharm Sci Technol; 1997; 51(3):104-10. PubMed ID: 9203822 [No Abstract] [Full Text] [Related]
2. Medicine, pharmacy, and industry--a fly's eye view of health care. Halperin JA Ann Pharmacother; 1995 Sep; 29(9):925-33. PubMed ID: 8547743 [No Abstract] [Full Text] [Related]
3. New drug development in the United States from 1963 to 1990. DiMasi JA; Bryant NR; Lasagna L Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):471-86. PubMed ID: 1934860 [No Abstract] [Full Text] [Related]
5. Emerging unscathed? Gershell LJ; Miller TA Nat Rev Drug Discov; 2002 Sep; 1(9):739. PubMed ID: 12216577 [No Abstract] [Full Text] [Related]
6. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium. Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179 [TBL] [Abstract][Full Text] [Related]
7. Being a modern pharmaceutical company: new paradigms for the pharmaceutical industry. Hassan F Clin Pharmacol Ther; 2001 May; 69(5):281-5. PubMed ID: 11371995 [No Abstract] [Full Text] [Related]
8. International diversification and US regulatory controls in the pharmaceutical industry. Goedde AG Q Rev Econ Bus; 1982; 22(1):101-10. PubMed ID: 10317195 [No Abstract] [Full Text] [Related]
9. The art and science of contemporary drug development. Gordon AJ; Gilgore SG Prog Drug Res; 1972; 16():194-210. PubMed ID: 4567340 [No Abstract] [Full Text] [Related]
10. New drug development in the United States from 1963 to 1999. Dimasi JA Clin Pharmacol Ther; 2001 May; 69(5):286-96. PubMed ID: 11371996 [No Abstract] [Full Text] [Related]
11. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy. Simmons HE Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901 [No Abstract] [Full Text] [Related]
13. Trends in antimicrobial drug development: implications for the future. Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341 [TBL] [Abstract][Full Text] [Related]
14. Biotechnology and the pharmaceutical industry. Rubin S Cancer Invest; 1993; 11(4):451-7. PubMed ID: 8324649 [No Abstract] [Full Text] [Related]
15. European Lead Factory hits its stride. Kingwell K Nat Rev Drug Discov; 2016 Apr; 15(4):221-2. PubMed ID: 27032822 [No Abstract] [Full Text] [Related]
16. Biotech on the brink. Taylor KS Hosp Health Netw; 1993 Sep; 67(17):36, 38. PubMed ID: 8353563 [No Abstract] [Full Text] [Related]
17. Compounding pharmacy oversight moves ahead. Traynor K Am J Health Syst Pharm; 2013 Jun; 70(11):920, 922, 924. PubMed ID: 23686593 [No Abstract] [Full Text] [Related]
18. Carlo Incerti. Incerti C Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428 [No Abstract] [Full Text] [Related]
19. Nevada law aims to halt drug diversion by wholesalers. Young D Am J Health Syst Pharm; 2002 Jan; 59(2):103-4. PubMed ID: 11826557 [No Abstract] [Full Text] [Related]
20. Standing on your own feet. Apple WS J Am Pharm Assoc; 1974 Jun; 14(6):278-80. PubMed ID: 4840422 [No Abstract] [Full Text] [Related] [Next] [New Search]